0,802  0,004  Antipsoriatic
0,797  0,004  Nitric oxide antagonist
0,797  0,016  Antiinflammatory
0,775  0,020  Apoptosis agonist
0,736  0,010  Antileukemic
0,714  0,001  Alcohol dehydrogenase substrate
0,710  0,007  CYP2C19 substrate
0,701  0,004  Macular degeneration treatment
0,688  0,012  Alzheimer's disease treatment
0,684  0,014  CYP2C9 substrate
0,687  0,025  Caspase 9 stimulant
0,664  0,010  CYP1A2 substrate
0,649  0,003  Antiacne
0,650  0,007  AR expression inhibitor
0,608  0,006  Ca2+/calmodulin-dependent protein kinase kinase A inhibitor
0,606  0,008  Antiprotozoal (Leishmania)
0,599  0,018  Prostate cancer treatment
0,596  0,015  Sensitization
0,593  0,030  CYP3A4 substrate
0,593  0,036  Antineoplastic (breast cancer)
0,564  0,009  FMO1 substrate
0,569  0,016  Mutagenic
0,553  0,005  Liver fibrosis treatment
0,544  0,027  Aldehyde oxidase inhibitor
0,553  0,037  Transcription factor NF kappa B inhibitor
0,516  0,001  Retinoic acid receptor agonist
0,518  0,020  Cardioprotectant
0,497  0,001  Aldehyde dehydrogenase substrate
0,496  0,020  Antineoplastic (brain cancer)
0,518  0,044  Analgesic
0,478  0,008  Skin whitener
0,476  0,013  Skin irritative effect
0,505  0,045  TNF expression inhibitor
0,476  0,026  Hepatic disorders treatment
0,479  0,031  Respiratory analeptic
0,452  0,005  Aldehyde dehydrogenase inhibitor
0,485  0,038  Antipruritic, allergic
0,451  0,015  Antihypoxic
0,450  0,027  Carcinogenic
0,457  0,037  Teratogen
0,447  0,034  CYP2D6 substrate
0,436  0,029  Antioxidant
0,434  0,032  Radioprotector
0,404  0,002  Transcription factor AP-1 inhibitor
0,439  0,039  Bone diseases treatment
0,420  0,028  Cardiovascular analeptic
0,426  0,039  Embryotoxic
0,393  0,012  UGT2B7 substrate
0,415  0,035  Antineoplastic (pancreatic cancer)
0,394  0,037  Cytotoxic
0,393  0,039  Analeptic
0,394  0,041  Antineoplastic (melanoma)
0,383  0,040  CTGF expression inhibitor
0,381  0,042  Antiosteoporotic
0,339  0,002  Retinoic acid beta receptor agonist
0,343  0,006  Neurotrophic factor
0,361  0,033  Chemopreventive
0,376  0,052  Antifungal
0,325  0,005  ABCA1 expression enhancer
0,360  0,041  UGT2B4 substrate
0,333  0,016  Interferon gamma antagonist
0,348  0,034  Antineoplastic (liver cancer)
0,330  0,034  Antiulcerative
0,341  0,053  Antihypercholesterolemic
0,291  0,004  Actinic keratosis treatment
0,355  0,068  Antineoplastic (non-Hodgkin's lymphoma)
0,315  0,032  UDP-glucuronosyltransferase substrate
0,293  0,011  Antifungal enhancer
0,331  0,049  Chemoprotective
0,314  0,032  Wound healing agent
0,322  0,044  Antineoplastic (renal cancer)
0,302  0,028  Eye irritation, high
0,275  0,002  Retinoic acid alpha receptor agonist
0,333  0,062  Calcium channel activator
0,313  0,044  Vascular (periferal) disease treatment
0,272  0,006  Porphobilinogen synthase inhibitor
0,300  0,035  Abortion inducer
0,266  0,005  TRPA1 agonist
0,278  0,025  CYP2B6 inhibitor
0,341  0,090  GST A substrate
0,286  0,036  UGT1A1 substrate
0,278  0,029  Pneumotoxic
0,313  0,064  Antineoplastic (small cell lung cancer)
0,274  0,027  Neurotrophic factor enhancer
0,255  0,014  Antitussive
0,256  0,016  Age-related macular degeneration treatment
0,261  0,023  Antiviral (Influenza A)
0,314  0,075  Immunostimulant
0,342  0,104  15-Lipoxygenase inhibitor
0,299  0,061  UGT1A9 substrate
0,271  0,038  Hepatoprotectant
0,291  0,058  Flavin-containing monooxygenase substrate
0,275  0,044  Antiparkinsonian, rigidity relieving
0,238  0,010  Androgen antagonist
0,253  0,026  Protein kinase stimulant
0,229  0,002  Retinoid X beta receptor agonist
0,316  0,092  Antineoplastic (lung cancer)
0,282  0,058  Proliferative diseases treatment
0,228  0,004  Ornithine decarboxylase inhibitor
0,226  0,006  Adenylate cyclase stimulant
0,229  0,009  Growth stimulant
0,242  0,023  UGT2B9 substrate
0,282  0,063  Antineoplastic (glioma)
0,290  0,072  Antineoplastic (multiple myeloma)
0,272  0,054  DNA synthesis inhibitor
0,236  0,018  UGT2B10 substrate
0,241  0,024  Alpha-N-acetylglucosaminidase inhibitor
0,244  0,030  3C-like protease (Human coronavirus) inhibitor
0,258  0,047  Anesthetic general
0,269  0,060  Cytostatic
0,207  0,001  Retinoic acid gamma receptor agonist
0,235  0,030  Lipid peroxidase inhibitor
0,333  0,131  5 Hydroxytryptamine release inhibitor
0,225  0,024  Cocaine dependence treatment
0,267  0,066  NOS2 expression inhibitor
0,239  0,039  Antipruritic, non-allergic
0,244  0,049  Antialcoholic
0,254  0,060  UGT1A6 substrate
0,198  0,009  Keratolytic
0,272  0,084  Antineoplastic (ovarian cancer)
0,260  0,072  Antipyretic
0,302  0,115  GABA C receptor rho-3 antagonist
0,276  0,091  Antineoplastic (osteosarcoma)
0,219  0,036  Succinate dehydrogenase inhibitor
0,262  0,083  GST M1-1 substrate
0,199  0,024  Toll-Like receptor 2 antagonist
0,209  0,039  UGT2B15 substrate
0,204  0,040  Phospholipase A2 inhibitor
0,242  0,078  Antineoplastic (cervical cancer)
0,232  0,069  Antineoplastic (glioblastoma multiforme)
0,165  0,002  Retinoid X gamma receptor agonist
0,241  0,079  Tumour necrosis factor alpha release inhibitor
0,252  0,090  Spasmolytic
0,198  0,042  Melanin inhibitor
0,290  0,135  CYP2C19 inhibitor
0,166  0,011  Anabolic
0,162  0,009  Purinergic P2X2 antagonist
0,200  0,051  Antianorexic
0,179  0,031  Movement disorders treatment
0,195  0,048  Phospholipase C inhibitor
0,177  0,031  Retinoprotector
0,238  0,093  5 Hydroxytryptamine uptake stimulant
0,145  0,002  Retinoic acid receptor gamma antagonist
0,156  0,014  GST T1-1 substrate
0,174  0,033  Glutathione S-transferase substrate
0,143  0,002  Retinoic acid receptor antagonist
0,157  0,017  Xanthine oxidase substrate
0,163  0,025  Contraceptive female
0,141  0,005  3(or 17)beta-hydroxysteroid dehydrogenase inhibitor
0,183  0,048  Contraceptive
0,149  0,015  UGT2B11 substrate
0,150  0,016  CYP2A6 inhibitor
0,139  0,006  Bcl2 antagonist
0,199  0,068  Antihelmintic
0,169  0,038  Antihyperlipoproteinemic
0,163  0,033  Ferrochelatase inhibitor
0,187  0,057  Antirickettsial
0,181  0,052  Arachidonic acid antagonist
0,183  0,055  Antiviral (Herpes)
0,207  0,080  Antineoplastic enhancer
0,137  0,010  GABA aminotransferase inhibitor
0,128  0,002  Retinoic acid alpha receptor antagonist
0,144  0,019  Phosphofructokinase-1 inhibitor
0,154  0,033  Ca2+-transporting ATPase inhibitor
0,128  0,009  CDC25B inhibitor
0,178  0,061  Aldehyde oxidase substrate
0,118  0,002  Retinoic acid beta receptor antagonist
0,238  0,123  Caspase 3 stimulant
0,140  0,025  Antiprotozoal (Toxoplasma)
0,192  0,077  5 Hydroxytryptamine 3E antagonist
0,234  0,119  FMO3 substrate
0,200  0,087  Antiparasitic
0,133  0,020  Antidote, mercury
0,205  0,093  RNA-directed DNA polymerase inhibitor
0,187  0,077  Growth factor agonist
0,124  0,014  Na+ K+ transporting ATPase inhibitor
0,152  0,044  Antismoking
0,162  0,054  SULT1A3 substrate
0,171  0,065  Prostate disorders treatment
0,110  0,004  Retinoid X alpha receptor agonist
0,188  0,082  Antiviral (Influenza)
0,167  0,062  Acaricide
0,238  0,133  ICAM1 expression inhibitor
0,142  0,038  Expectorant
0,128  0,025  Paget's disease treatment
0,141  0,038  CC chemokine 6 receptor antagonist
0,240  0,138  Apoptosis antagonist
0,189  0,086  Psychostimulant
0,118  0,017  Granulocyte macrophage colony stimulating factor agonist
0,143  0,042  Carcinogenic, group 2B
0,190  0,091  Antihypertriglyceridemic
0,102  0,004  Pregnane X receptor antagonist
0,263  0,165  Antibacterial
0,101  0,005  Retinoid X receptor agonist
0,101  0,005  Anesthetic inhalation
0,155  0,060  Mannose-6-phosphate isomerase inhibitor
0,169  0,074  UGT1A4 substrate
0,138  0,045  Microtubule formation inhibitor
0,155  0,062  Antineoplastic (squamous cell carcinoma)
0,152  0,061  Anesthetic
0,153  0,061  CNS active muscle relaxant
0,172  0,082  LDLR expression enhancer
0,133  0,044  Mucolytic
0,108  0,020  Aromatase inhibitor
0,136  0,048  Sphingosine 1-phosphate receptor 4 antagonist
0,181  0,094  Insulin sensitizer
0,126  0,040  UDP-glucose 4-epimerase inhibitor
0,129  0,044  GABA C receptor agonist
0,142  0,058  Carcinogenic, group 3
0,109  0,026  Glutamate dehydrogenase inhibitor
0,158  0,077  UGT1A3 substrate
0,081  0,002  Retinoid X gamma receptor antagonist
0,283  0,204  Antineoplastic (solid tumors)
0,087  0,011  Heme oxygenase stimulant
0,094  0,018  Purinergic P2X1 antagonist
0,112  0,036  Thioredoxin inhibitor
0,085  0,011  5-Alpha-reductase inhibitor
0,203  0,130  Tyrosine 3 hydroxylase inhibitor
0,124  0,052  Excitatory amino acid transporter EAAC1 inhibitor
0,130  0,059  Adenylate cyclase inhibitor
0,120  0,050  HDL-cholesterol increasing
0,131  0,062  Cathepsin H inhibitor
0,179  0,110  Hypolipemic
0,098  0,031  Thioredoxin reductase inhibitor
0,202  0,135  Antiepileptic
0,085  0,019  Antimycoplasmal
0,068  0,004  Retinoid X receptor antagonist
0,183  0,119  Antineoplastic (non-small cell lung cancer)
0,146  0,083  CF transmembrane conductance regulator agonist
0,105  0,044  Antineoplastic antibiotic
0,229  0,167  Immunosuppressant
0,076  0,016  Postcoital contraceptive
0,101  0,041  Glutamate release inhibitor
0,070  0,012  Adenylate cyclase 1 inhibitor
0,060  0,004  Retinoid X alpha receptor antagonist
0,107  0,052  Estrogen receptor beta antagonist
0,087  0,032  Antidote, organophosphates
0,184  0,130  Antihypotensive
0,103  0,051  UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor
0,132  0,081  Antiparkinsonian, tremor relieving
0,088  0,037  Estrogen receptor alpha antagonist
0,136  0,085  Pregnane X receptor agonist
0,113  0,062  Myasthenia Gravis treatment
0,099  0,049  Triose-phosphate isomerase inhibitor
0,103  0,053  Electrolyte absorption antagonist
0,117  0,066  Transcription factor STAT6 inhibitor
0,060  0,011  Parathyroid hormone antagonist
0,241  0,193  Transcription factor inhibitor
0,143  0,096  Carcinogenic, group 1
0,180  0,134  DNA damaging
0,097  0,054  Antiviral (Rhinovirus)
0,045  0,003  Retinoid X beta receptor antagonist
0,054  0,012  Alpha 1L adrenoreceptor agonist
0,063  0,021  Glucose-6-phosphate translocase inhibitor
0,111  0,070  Photosensitizer
0,114  0,074  Alkylator
0,128  0,088  Antimutagenic
0,131  0,092  Genotoxic
0,139  0,100  Muscle relaxant
0,088  0,050  Inducible nitric-oxide synthase inhibitor
0,111  0,074  Menstruation disorders treatment
0,073  0,037  SULT2A1 substrate
0,188  0,153  Lipoxygenase inhibitor
0,178  0,143  5 Hydroxytryptamine release stimulant
0,044  0,012  Tubulin agonist
0,120  0,088  Vanilloid 1 agonist
0,177  0,146  Superoxide dismutase inhibitor
0,149  0,119  Phobic disorders treatment
0,052  0,024  Estradiol 17 beta-dehydrogenase inhibitor
0,053  0,025  Glucose-6-phosphate isomerase inhibitor
0,078  0,051  Narcotic antagonist
0,160  0,134  Antineoplastic (lymphocytic leukemia)
0,100  0,074  Choleretic
0,075  0,050  Vanilloid 4 agonist
0,040  0,015  Estradiol 17 beta-dehydrogenase 3 inhibitor
0,190  0,165  Gastrin inhibitor
0,100  0,075  DOPA decarboxylase inhibitor
0,107  0,082  Estrogen antagonist
0,053  0,029  Squalene epoxidase inhibitor
0,097  0,073  Adenylate kinase inhibitor
0,060  0,037  Argininosuccinate synthase inhibitor
0,072  0,049  Histidine decarboxylase inhibitor
0,072  0,051  Glycine receptor agonist
0,065  0,044  Protease 3C (Human rhinovirus) inhibitor
0,042  0,022  Progesterone antagonist
0,128  0,109  Prostatic (benign) hyperplasia treatment
0,050  0,030  Cholesterol esterase inhibitor
0,099  0,080  SULT1A1 substrate
0,031  0,012  Nicotinic acid receptor 2 antagonist
0,035  0,016  Glutamate (mGluR3) agonist
0,074  0,056  NAD(P)H dehydrogenase (quinone) inhibitor
0,042  0,024  GABA uptake inhibitor
0,095  0,078  Beta glucuronidase inhibitor
0,059  0,043  Potassium channel intermediate-conductance Ca-activated blocker
0,052  0,036  Aconitate hydratase inhibitor
0,042  0,027  Kainate receptor agonist
0,023  0,009  Progesterone receptor B antagonist
0,178  0,163  Radiosensitizer
0,027  0,013  Estradiol 17 beta-dehydrogenase 1 inhibitor
0,024  0,012  Vitamin D receptor antagonist
0,034  0,021  Catechol O-methyltransferase inhibitor
0,049  0,038  Prolyl endopeptidase inhibitor
0,026  0,016  Vanilloid 2 agonist
0,099  0,089  Cholesterol synthesis inhibitor
0,078  0,068  GABA A receptor agonist
0,180  0,170  Antineoplastic (bladder cancer)
0,128  0,118  Dual specificity phosphatase 3 inhibitor
0,038  0,029  Membrane dipeptidase inhibitor
0,036  0,027  2,3-Oxidosqualene-lanosterol cyclase inhibitor
0,065  0,057  Anticholelithogenic
0,107  0,099  Bone formation stimulant
0,077  0,069  Antineoplastic alkaloid
0,076  0,068  Carcinogenic, group 2A
0,044  0,037  Potassium channel Kv1.3 blocker
0,059  0,053  Antiemphysemic
0,019  0,014  5-Alpha-reductase 2 inhibitor
0,050  0,045  Alcohol oxidase inhibitor
0,017  0,012  Telomerase stimulant
0,080  0,075  NADH dehydrogenase inhibitor
0,053  0,048  Biliverdin reductase inhibitor
0,074  0,070  Antispirochetal
0,063  0,059  Glutamate (mGluR6) antagonist
0,020  0,017  GABA transporter inhibitor
0,210  0,206  Antineoplastic (endocrine cancer)
0,019  0,016  Antibiotic Quinolone-like
0,083  0,079  Restless leg syndrome treatment
0,066  0,063  Acetylcholine M4 receptor antagonist
0,015  0,013  GABA transporter 1 inhibitor
0,058  0,056  Sphingosine 1-phosphate receptor 4 agonist
0,047  0,045  Histamine agonist
0,040  0,038  Geranyltranstransferase inhibitor
0,092  0,091  GABA C receptor antagonist
0,039  0,037  Nicotinic receptor alpha3 subunit antagonist
0,032  0,031  Nicotinic acid receptor agonist

